of the Year
The University of Virginia Patent Foundation has named George T. Gillies, a research professor in mechanical and biomedical engineering at U.Va., as the recipient of the 14th annual Edlich-Henderson Inventor of the Year Award.
Gillies is being recognized for two decades of work in developing innovative catheters for use in brain surgery.
“Until very recently, George’s technology was ahead of its time,” said Robert S. MacWright, executive director of the U.Va. Patent Foundation.“ It’s taken a very long time to see the technology mature. But we’re extremely optimistic that it will have a revolutionary impact on how medicine is practiced. It shows particular promise in the treatment of brain cancer and complex brain diseases that today are simply untreatable with existing tools and methods because using them would cause unacceptable damage to the brain.”
disease affects millions of people. In the United States alone,
the Centers for Disease Control
and Prevention estimated that in 2003 there
To combat these debilitating diseases, the medical research community is actively developing new therapies in laboratories around the world. But there is a parallel challenge: how can the treatments be delivered effectively inside the brain without damaging vital brain tissue in the process?
That’s where Gillies’ work comes in.
In the 20 years that Gillies, his colleagues and their students have been seeking better ways to help doctors treat brain disease, his efforts have taken two different tracks. The first track involved working with a team of physician-researchers to develop a catheter that could be magnetically guided through the blood vessels of the brain to reach the precise spot where treatment was needed. A surgeon using this technology would direct the magnetic tip of the catheter into the brain using a computer that controlled the magnetic guidance system.
system was originally conceived by Dr. Matthew A. Howard III,
a medical student at
U.Va. in the mid-1980s, Dr. Sean Grady, then a
neurosurgery resident here, and Rogers C. Ritter,
then a U.Va. professor of physics. Gillies and others
joined them in developing the magnetic
guidance system that is currently licensed by a
publicly held company, Stereotaxis Inc., of St.
Louis. Dozens of Stereotaxis systems are now in
use in hospitals in Europe and the United States
and others may soon be installed in Asia.
The second series of inventions solves a number of problems that can accompany medical treatments delivered into the brain by catheter. The problems include: how to prevent air from being trapped inside the catheter during insertion; how to prevent the uneven distribution of fluids pumped into the brain during infusion therapies; how to prevent damage to blood vessels and brain tissue from multiple insertions of the catheter; how to make sure an adequate amount of drugs, cells or other therapeutic agents are delivered; how to make sure that therapy cells are alive when they are released. Gillies and his collaborators — Dr. William Broaddus and Helen Fillmore, both on the neurosurgery faculty at VCU, and John Kucharczyk, professor of radiology at the University of Minnesota— came up with a tube-within-a-tube design that solves several of these problems. By inserting a smaller tube inside a larger tube (both with diameters of approximately 1-2 millimeters), and leaving a bit of space between the two, excess air can be forced out through the space between the tubes, rather than being forced deeper into the brain tissue. If multiple insertions are required, the outer tube can be left in place and the inner tube can be withdrawn and reinserted without causing additional trauma to the surrounding tissue. And, by attaching optical fibers to the tubes, researchers can visually monitor the viability of cells in fluids being pumped through the catheters.
The U.S. Food and Drug Administration has approved the “Cell Delivery Catheter and Method” for use and the U.Va. Patent Foundation and its partners have licensed the invention to NexGen Medical Systems, Inc., a privately held company in Sacramento, Calif. Discussions regarding the licensing and commercialization of several derivative technologies are currently underway with the same company.
In all, Gillies is listed as a co-inventor on nine issued patents and as the inventor or co-inventor on another 30 patent disclosures, provisional patent filings or patent applications. U.Va. Patent Foundation officials have been impressed with the simple genius of Gillies’ work.
“George has incorporated his understanding of fluid dynamics into the design of a catheter that offers a simple and elegant way to deliver drugs into the brain,” said Veena Rao, a Patent Foundation licensing associate handling the licensing of Gillies’ inventions.“ It is a tour de force of technological advancement and one of the most impressive innovations resulting from University research that I’ve seen,” added Alan Bentley, Patent Foundation associate director.
Gillies enjoys the interdisciplinary nature of his work and freely shares credit with his collaborators.“ I’m very grateful to the Patent Foundation for giving me this award, but it really is a reflection of the contributions of all of us,” he said. All of the patents on which Gillies is named as co-inventor involved interdisciplinary work and“ required the participation of several highly talented individuals to accomplish the work,” said Joseph A. C. Humphrey, U.Va. professor of mechanical and aerospace engineering.“ However, in my opinion, Professor Gillies has been the principal intellectual engine driving the collaborations.”
Gillies, who was honored on May 15 at a banquet at the Boar’s Head Inn, received a plaque and a cash award of $10,000.
2006 by the Rector and Visitors